GL1X · GenesisL1 explorer

MolNFT v1 · #90527 · protein

Staphylococcus aureus marr in complex with salicylate and kanamycin

4EM0 · Uncharacterized hth-type transcriptional regulator SAR2349: “Staphylococcus aureus marr in complex with salicylate and kanamycin”. X-ray diffraction, 2 ligands (SAL, KAN), 3 pockets (best druggability 0.44). MolNFT v1 #90527 on…

PDB
4EM0
Type
protein
Length
150 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uncharacterized hth-type transcriptional regulator SAR2349
UniProt
Q6GEG9
Ligands
SAL, KAN
Pockets
3 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 68% helix, 6% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BUncharacterized hth-type transcriptional regulator SAR2349protein15068% helix, 6% strandQ6GEG9

Ligands and binding sites

  • SAL · 2-hydroxybenzoic acid · ligand · chains B
  • KAN · Kanamycin A · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1600.440.8210SAL
21410.440.7517KAN
3580.310.7514empty

Compared structures

  • 4EM0 · staphylococcus aureus MarR in complex with salicylate and kanamycin · the same entry in another collection · chain B against B, TM-score 1.00
  • Q6GEG9 · AlphaFold monomer V2.0 prediction for uncharacterized hth-type transcriptional regulator… · a predicted model of the same protein · chain B against A, TM-score 0.87

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.